Cargando…
Designed SARS‐CoV‐2 receptor binding domain variants form stable monomers
The receptor binding domain (RBD) of the SARS‐CoV‐2 spike (S)‐protein is a prime target of virus‐neutralizing antibodies present in convalescent sera of COVID‐19 patients and thus is considered a key antigen for immunosurveillance studies and vaccine development. Although recombinant expression of R...
Autores principales: | Klausberger, Miriam, Kienzl, Nikolaus F., Stadlmayr, Gerhard, Grünwald‐Gruber, Clemens, Laurent, Elisabeth, Stadlbauer, Katharina, Stracke, Florian, Vierlinger, Klemens, Hofner, Manuela, Manhart, Gabriele, Gerner, Wilhelm, Grebien, Florian, Weinhäusel, Andreas, Mach, Lukas, Wozniak‐Knopp, Gordana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011732/ https://www.ncbi.nlm.nih.gov/pubmed/35078277 http://dx.doi.org/10.1002/biot.202100422 |
Ejemplares similares
-
Impact of Specific N-Glycan Modifications on the Use of Plant-Produced SARS-CoV-2 Antigens in Serological Assays
por: Schwestka, Jennifer, et al.
Publicado: (2021) -
N-Glycosylation of the SARS-CoV-2 Receptor Binding Domain Is Important for Functional Expression in Plants
por: Shin, Yun-Ji, et al.
Publicado: (2021) -
Bispecific antibodies with Fab-arms featuring exchanged antigen-binding constant domains
por: Benedetti, Filippo, et al.
Publicado: (2021) -
A Tetravalent Biparatopic Antibody Causes Strong HER2 Internalization and Inhibits Cellular Proliferation
por: Benedetti, Filippo, et al.
Publicado: (2021) -
Bispecific mAb(2) Antibodies Targeting CD59 Enhance the Complement-Dependent Cytotoxicity Mediated by Rituximab
por: Stadlbauer, Katharina, et al.
Publicado: (2022)